当前位置: X-MOL 学术BMJ Open Respir. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience
BMJ Open Respiratory Research ( IF 4.1 ) Pub Date : 2021-07-01 , DOI: 10.1136/bmjresp-2021-000962
Kamran Mahmood 1 , Matt Abbott 2 , Keriann Van Nostrand 3 , Rabih Bechara 4 , Anne V Gonzalez 5 , Amanda Brucker 6 , Cynthia L Green 6 , Christopher R Polage 7
Affiliation  

Objective For the diagnosis of COVID-19, the yield of nasopharyngeal (NP) swabs is unclear, and bronchoalveolar lavage (BAL) is obtained to confirm the diagnosis. We assessed the utilisation of bronchoscopy for COVID-19 diagnosis in a multicenter study and compared the diagnostic yield of BAL versus NP swabs. Methods This retrospective study included all patients who were admitted with clinical presentation concerning for COVID-19 and underwent BAL from 1 March to 31 July 2020 at four tertiary care centres in North America. We also compared concordance of BAL with NP swabs for diagnosis of COVID-19 infection. Results Fifty-three patients, with clinical suspicion for COVID-19 and admitted for respiratory failure, underwent bronchoscopy to collect BAL for SARS-CoV-2 testing. During the same period, 2039 bronchoscopies were performed on patients not infected with COVID-19. Of 42 patients with NP swabs and BAL collected within ≤7 days, 1 was NP swab negative but positive by BAL for SARS-CoV-2 (n=1/42 (2.4%)). Across a wide array of testing platforms, the overall agreement between NP swabs and BAL results was 97.6% (95% CI: 93.0% to 100%) with Cohen’s k of 0.90 (95% CI: 0.69 to 1.00). The sensitivity, specificity, positive and negative predictive values of NP swabs compared with BAL were 83.3% (95% CI: 53.5% to 100%), 100%, 100% and 97.3% (95% CI: 92.1% to 100%), respectively. Conclusions BAL was used infrequently to assess COVID-19 in busy institutions. NP swabs have a high concordance with BAL for COVID-19 testing, but negative NP swabs should be confirmed with BAL when clinical suspicion is high. Data are available upon reasonable request.

中文翻译:

支气管镜检查评估 COVID-19 呼吸道感染的利用率低:多中心经验

目的 对于 COVID-19 的诊断,鼻咽 (NP) 拭子的产量尚不清楚,并获得支气管肺泡灌洗 (BAL) 以确认诊断。我们在一项多中心研究中评估了支气管镜检查在 COVID-19 诊断中的应用,并比较了 BAL 与 NP 拭子的诊断率。方法 这项回顾性研究纳入了 2020 年 3 月 1 日至 7 月 31 日在北美四个三级医疗中心因 COVID-19 临床表现入院并接受 BAL 的所有患者。我们还比较了 BAL 与 NP 拭子在 COVID-19 感染诊断中的一致性。结果 53 名临床怀疑 COVID-19 并因呼吸衰竭入院的患者接受了支气管镜检查以收集 BAL 进行 SARS-CoV-2 检测。同一时期,对未感染 COVID-19 的患者进行了 2039 次支气管镜检查。在 ≤ 7 天内收集到 NP 拭子和 BAL 的 42 名患者中,1 名 NP 拭子呈阴性,但 SARS-CoV-2 的 BAL 呈阳性(n=1/42(2.4%))。在各种测试平台中,NP 拭子和 BAL 结果之间的总体一致性为 97.6%(95% CI:93.0% 至 100%),Cohen's k 为 0.90(95% CI:0.69 至 1.00)。与 BAL 相比,NP 拭子的敏感性、特异性、阳性和阴性预测值分别为 83.3%(95% CI:53.5% 至 100%)、100%、100% 和 97.3%(95% CI:92.1% 至 100%) , 分别。结论 BAL 在繁忙的机构中很少用于评估 COVID-19。对于 COVID-19 检测,NP 拭子与 BAL 高度一致,但当临床高度怀疑时,应使用 BAL 确认阴性 NP 拭子。可应合理要求提供数据。
更新日期:2021-07-24
down
wechat
bug